Effect of Acute Sleep Restriction on Responses to Hypoxia
NCT ID: NCT05563688
Last Updated: 2022-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2022-10-26
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The countermeasure to altitude hypoxia is oxygen but its use is not systematic between 3000 and 4000 m. Its use depends on the duration of exposure, without clearly established standards. Incapacitating effects on the operational capacity and health of soldiers can therefore occur as early as 3500 m.
In operations or during training, altitude exposure is often associated with a significant sleep debt (particularly during night or early morning missions), jet lag or precarious rest conditions in overseas operations. These sleep restrictions promote the degradation of mental performance with effects similar to those observed in hypoxia.
The combination of these constraints induces a physiological stress which can favour alterations in mental performance, an increase in incapacity, intolerance to altitude or the occurrence of altitude-related pathologies in military personnel. This could occur in particular in the operational zone around the threshold of disorders (3500 m) where the indication of oxygen is discussed.
The objective of this study is to assess the impact of acute sleep restriction on hypoxia tolerance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Mild Hypobaric Hypoxia on Sleep and Post-sleep Performance
NCT00498563
Sleep and Cerebral Responses to High Altitude
NCT01565603
Neuropsychological Sleep Physical Exercise Hypoxia
NCT01386814
Combined Effects of Acute Sleep Restriction and Moderate Acceleration (+Gz) on Physiological and Behavioral Responses to High Mental Workload
NCT06017882
Effects of Mild Hypobaric Hypoxia on Oxygen Saturation During Sleep
NCT00659009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypoxia exposure
Each participant will be exposed to the hypoxic environment on 2 occasions (one after a normal sleep night and one after sleep deprivation).
Each exposure will be for 5 hours at a FiO2 of 13.2% (3500 m simulated altitude).
This exposure will be carried out in a normobaric hypoxic tent (Sporting Edge®).
Sleep deprivation
Each participant will be exposed to sleep deprivation on 2 occasions (one before normoxia exposure and one before hypoxia exposure).
Each sleep deprivation involves a time spent in bed of 3 hours (03h00 - 06h00). Sleep deprivation will be carried out in a sleep apartment. Sleep duration and quality will be assessed using a sleep headband (Dreem®), actigraphs Actiwatch® and E4 Empatica®) and a sleep diary.
Cognitive tasks
Participants will perform several cognitive tasks in the following conditions:
* in normoxia (FiO2 = 21%) after a night of usual sleep (\> 6 hours) ;
* in normoxia (FiO2 = 21%) after a night of reduced sleep (3 hours);
* in normobaric hypoxia (FiO2 = 13.2%) after a night of normal sleep (\> 6 hours);
* in normobaric hypoxia (FiO2 = 13.2%) after a night of reduced sleep (3 hours).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy
* Between 18 and 45
* Smoking \< 5 cigarettes per day or nicotine-free electronic cigarette
* Having regular physical activity (between 1 and 4 hours of physical activity per week)
* Affiliated or entitled to a social security plan
* No contraindication to physical exercise
* Having given their consent
Exclusion Criteria
* BMI \> 30
* Active medical pathology (cardiological, renal, hepatic, cutaneous, neurological, etc.),
* History of active pathology of less than 6 months
* Significant deviation with the normal values observed during the interrogation, clinical examination or electrocardiogram
* Having spent time at altitude (\> 3500 m) during the last 3 months
* Absolute or relative contraindication to a stay at high altitude
* Medical contraindication to sport practice
* Skin allergy to modified ethanol or capsaicin
* Wearing a pacemaker or ferromagnetic implants
* Poor venous capital
* Pittsburgh Sleep Quality Index Questionnaire \> 5
* Usual sleep duration \< 6 hours
* Not covered by a health insurance plan
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de Recherche Biomédicale des Armées
Brétigny-sur-Orge, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00464-39
Identifier Type: OTHER
Identifier Source: secondary_id
2021PBMD09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.